Immune cells work together to enable successful cancer therapy

Morgan McSweeney A group of researchers from the University of California – San Francisco recently found that the presence of a certain group of immune cells in tumors (“stimulatory dendritic cells,” or SDCs) can predict better cancer outcomes, at least in melanoma patients. For example, in patients treated with checkpoint inhibitors (drugs that work by…